Yubo International Biotech Ltd (YBGJ): Total Liabilities
$2.79M
As of 2025-12-31
$3.33M
As of 2026-06-30
-1.4%
3-year compound annual growth
+16.9%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.79M | -42.2% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $4.83M | +37.6% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $3.51M | +20.5% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $2.91M | -38.2% | 2024-04-12, Balance as of period end |
| 2021-12-31 | $4.72M | +269.4% | 2023-04-14, Balance as of period end |
| 2020-12-31 | $1.28M | n/a | 2022-04-15, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Yubo International Biotech Ltd (YBGJ) | 2025-12-31 | $2.79M | -42.2% |
| Nexalin Technology, Inc. (NXL) | 2025-12-31 | $887.3K | +62.3% |
| Positron Corp (POSC) | 2025-12-31 | $2.56M | +4.0% |
| iTonic Holdings Ltd (ITOC) | 2025-12-31 | $969.8K | +80.1% |
| Guided Therapeutics Inc (GTHP) | 2025-12-31 | $7.33M | +17.0% |
| Hongchang International Co., Ltd (HCIL) | 2024-12-31 | $18.68M | +92.0% |
| ADM Tronics Unlimited, Inc. (ADMT) | 2026-03-31 | $1.26M | -13.8% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $3.00M | +11.7% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $3.49M | +4.6% |
Compare YBGJ, NXL, POSC, ITOC side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗